Consider stopping dengvaxia administration without immunological screening
Main Authors: | Maíra Aguiar, Scott B. Halstead, Nico Stollenwerk |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-04-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2017.1276831 |
Similar Items
-
A review of Dengvaxia®: development to deployment
by: Stephen J. Thomas, et al.
Published: (2019-10-01) -
Identification of prior dengue-naïve Dengvaxia recipients with an increased risk for symptomatic dengue during fever surveillance in the Philippines
by: Yu-Ching Dai, et al.
Published: (2023-07-01) -
Vaccine Hesitancy and the Cultural Politics of Trust in the Dengvaxia Controversy: A Critical Discourse-Ethnographic Study of Online News Content, Producers, and Audiences
by: Karl Patrick Mendoza
Published: (2020-12-01) -
Optimal Control of a Dengue-Dengvaxia Model: Comparison Between Vaccination and Vector Control
by: Mentuda Cheryl Q.
Published: (2021-11-01) -
REVIEW ARTICLE: DEVELOPEMENT AND USING DENGUE VACCINE FOR DENGUE INFECTION VIRUS
by: Firdaus Kabiru Massey, et al.
Published: (2019-08-01)